TY - JOUR
T1 - Chemoprevention of cancer
AU - Tsao, Anne S.
AU - Kim, Edward S.
AU - Hong, Waun Ki
PY - 2004
Y1 - 2004
N2 - Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The success of several recent clinical trials in preventing cancer in high-risk populations suggests that chemoprevention is a rational and appealing strategy. This review will highlight current clinical research in chemoprevention, the biologic effects of chemopreventive agents on epithelial carcinogenesis, and the usefulness of intermediate biomarkers as markers of premalignancy. Selected chemoprevention trials are discussed with a focus on strategies of trial design and clinical outcome. Future directions in the field of chemoprevention will be proposed that are based on recently acquired mechanistic insight into carcinogenesis.
AB - Cancer chemoprevention is defined as the use of natural, synthetic, or biologic chemical agents to reverse, suppress, or prevent carcinogenic progression to invasive cancer. The success of several recent clinical trials in preventing cancer in high-risk populations suggests that chemoprevention is a rational and appealing strategy. This review will highlight current clinical research in chemoprevention, the biologic effects of chemopreventive agents on epithelial carcinogenesis, and the usefulness of intermediate biomarkers as markers of premalignancy. Selected chemoprevention trials are discussed with a focus on strategies of trial design and clinical outcome. Future directions in the field of chemoprevention will be proposed that are based on recently acquired mechanistic insight into carcinogenesis.
UR - http://www.scopus.com/inward/record.url?scp=2942655078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2942655078&partnerID=8YFLogxK
U2 - 10.3322/canjclin.54.3.150
DO - 10.3322/canjclin.54.3.150
M3 - Review article
C2 - 15195789
AN - SCOPUS:2942655078
SN - 0007-9235
VL - 54
SP - 150
EP - 180
JO - Ca-A Cancer Journal for Clinicians
JF - Ca-A Cancer Journal for Clinicians
IS - 3
ER -